Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Tylenol Liver Damage Litigation

The Firm is evaluating Tylenol lawsuits on behalf of individuals who allegedly suffered serious liver damage due to the acetaminophen contained in Tylenol-brand over-the-counter medications.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Free Case Review
Our Firm has heard from numerous individuals who allegedly suffered acetaminophen-induced liver damage from Tylenol products. We are pleased to see this litigation moving forward.

New York, New York (PRWEB) April 13, 2014

Tylenol lawsuits (http://www.tylenollawsuitcenter.com/) that allege the acetaminophen contained in Tylenol-brand over-the-counter medications caused severe liver damage in some users continue to move forward in Pennsylvania federal court, Bernstein Liebhard LLP reports. According to court documents filed in the U.S. District Court, Eastern District of Pennsylvania, the proceeding’s next Status Conference has been scheduled for Tuesday, April 15, 2014 at 10:00 a.m. According to an Order issued on January 8, 2014, liaison counsel has been directed to submit a proposed agenda to the Court at least two days prior to the conference. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

“Our Firm has heard from numerous individuals who allegedly suffered acetaminophen-induced liver damage from Tylenol products. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is offering free legal reviews to consumers who were allegedly harmed by a Tylenol-brand over-the-counter medication.

Tylenol Liver Damage Allegations
The Philadelphia Inquirer reported in February that some 78,000 people require emergency room care every year due to toxic reactions to acetaminophen, the active ingredient in Tylenol-brand products. Such injuries also result in about 33,000 hospitalizations every year.* In 2011, the U.S. Food & Drug Administration (FDA) announced that it would limit the amount of acetaminophen in prescription medications to 325 mg per tablet. According to a notice posted on the Federal Register, the new limits went into affect on January 14, 2014.

In August 2013, Bloomberg.com reported that over-the-counter Extra Strength Tylenol caplets each contain 500 mg of acetaminophen, well over the new limits for prescription medications set by the FDA. That same month, Johnson & Johnson’s McNeil Consumer Healthcare unit announced that it would add new, more prominent warnings regarding the risk of liver damage to the labels of Tylenol-brand medications.**

Court documents indicate that more than 120 Tylenol lawsuits have been filed in the Eastern District of Pennsylvania on behalf of individuals who allegedly suffered liver damage from Tylenol products, even when the over-the-counter medications were used in accordance with label directions. Among other things, these lawsuits claim that Johnson & Johnson and McNeil failed to provide the public with adequate warnings regarding the association between Tylenol and liver damage.

Individuals who allegedly suffered liver damage resulting in hospitalization, liver transplantation, or death due to the acetaminophen in a Tylenol-brand over-the-counter medication may be entitled to compensation for injury-related damages. To find out more about filing a Tylenol lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free legal review, please call 800-511-5092.

*articles.philly.com/2014-02-17/news/47382323_1_acetaminophen-poisoning-tylenol-maker-kate-trunk, Philadelphia Inquirer, February 17, 2014
**bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.tylenollawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author